Biotechnology Stocks II Performance Guide: Phathom Pharmaceuticals, Inc. (PHAT)
PHAT has no dividends.
Table and Chart of PHAT Performance
See what a $1,000 investment in PHAT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PHAT Returns | |
|---|---|
| Start Date | Nov-29-2019 |
| Start Price | $25.60 |
| End Date | May-16-2024 |
| End Price | $10.69 |
| # Prices | 55 |
| Min Date | Jan-31-2024 |
| Min Price | $6.70 |
| Max Date | Feb-26-2021 |
| Max Price | $44.05 |
| Total Return | -58.24% |
| Annualized Return | -17.35% |
| Current Value of $1,000 Purchase | $418 |
| Number Returns | 1,485 |
| Average Return | -34.94% |
| Number Profitable Returns | 320 |
| Percent Profitable Returns | 21.55% |
| Number Unprofitable Returns | 1,165 |
| Percent Unprofitable Returns | 78.45% |
| Profitable to Unprofitable Returns Ratio | 0.27 |
| PHAT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $609,351,000 |
| Beta | 0.668 | Price to Sales | 869.44 |
| Earnings per Share | $-4.4600 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 25.37 |
| PRICE DATA | |
| 52 Week High | $17.02 |
| 52 Week Low | $6.07 |
| Analyst Target Price | $22.88 |
| 50-Day Moving Average | $9.75 |
| 200-Day Moving Average | $9.86 |
| FINANCIAL DATA | |
| Revenue per Share | $0.047 |
| Revenue | $2,594,000 |
| Profit Margin | 0% |
| Return on Equity | -3489% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PHAT Compare Returns with S&P 500
PHAT Trendline Chart
PHAT Moving Average Chart
PHAT Stock Return Map - See Patterns of Gains and Losses
PHAT Stock Returns/Purchase Dates